Are you Dr. Kannan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 26 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
263 Farmington Ave
Farmington, CT 06030Phone+1 860-679-2000- Is this information wrong?
Summary
- Dr. Subramanian Kannan, MD is an endocrinologist in Farmington, Connecticut. He is currently licensed to practice medicine in Ohio.
Education & Training
Cleveland Clinic FoundationFellowship, Endocrinology, Diabetes, and Metabolism, 2011 - 2013
University of ConnecticutResidency, Internal Medicine, 2007 - 2010
Stanley Medical College SMCClass of 2003
Certifications & Licensure
OH State Medical License Active through 2013- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- Dorsal vertebral body tumor and non-compressive quadriparesis - A rare case report of a phosphaturic mesenchymal tumor.Mrudul Mohinish Bhatjiwale, Komal Prasad Chandrachari, Subramanian Kannan> ;Surgical Neurology International. 2022 Jan 1
- Phosphaturic Mesenchymal Tumor Masquerading as Mesenchymal Tumors with Diverse Differential Diagnosis: Series of 4 Cases with Emphasis on Histomorphological SpectrumR. T. Rajeswarie, Akhila Lakshmikantha, Subramanian Kannan, Vijay Pillai, Komal Prasad> ;Indian Journal of Surgical Oncology. 2021 Apr 28
- 1 citationsIs Paget Disease of Bone a Predominant Disease of South India? Clinical Characteristics, Therapeutic Outcome and Follow Up of 66 Patients from Tamil Nadu and Brief Rev...Adlyne Reena Asirvatham, Subramanian Kannan, Shriraam Mahadevan, Karthik Balachandran, Geethalakshmi Sampathkumar, Dhalapathy Sadacharan, Satish K Balasubramanian> ;Indian Journal of Endocrinology and Metabolism. 2020 Nov 1
- Join now to see all
Press Mentions
Battling the Bulge: The Rising Fame of Two Drugs Among Obesity PatientsMarch 20th, 2023
